Randall B. Sunberg is a partner in Morgan Lewis's Business and Finance Practice, vice chair of the firm's Life Sciences Interdisciplinary Group, co-chair of the firm's Life Sciences Transactions Practice, and Managing Partner of the Princeton office.

Mr. Sunberg's clients range from early-stage biotechnology start-ups to global pharmaceutical companies, as well as specialty pharma, medical device, diagnostics, and other technology companies. He also advises private equity, venture capital, and investment banking firms focused on the life sciences industry. Mr. Sunberg's background includes a variety of transactions, including negotiating and structuring complex collaborations, mergers and acquisitions, divestitures, joint ventures, corporate partnering and licensing, and the equity investments that often accompany such transactions. Related matters include: alternative financing arrangements such as royalty monetizations; technical contractual arrangements for drug discovery, development, manufacturing and supply; marketing and co-promotion transactions; and outsourcing in the life sciences industry. He also advises boards of directors and significant shareholders on disclosure issues, corporate communications policies, and fiduciary duty matters.

Mr. Sunberg has spoken on the subjects of mergers and acquisitions, strategic alliances, and licensing and collaboration transactions in the United States at Allicense, BIO Annual Meetings and LES Annual Meetings, in Canada at BIOMedex, and in China at BIOForum, as well as at other life-sciences-related conferences and as guest lecturer at the Rutgers Business School MBA Biotechnology Commercialization Concentration.

Mr. Sunberg is admitted to practice in New Jersey, Pennsylvania, New York, and Missouri.